/MGRO.V

MGRO.V Stock - MustGrow Biologics Corp.

Q: What is the analyst price target for MGRO.V?

Analyst price target information is not currently available for MGRO.V.

Q: What is MGRO.V's market cap?

Market capitalization information is not currently available for MGRO.V.

Basic Materials|Agricultural Inputs|TSXV

$0.71+4.41%

+$0.03 (+4.41%) • Dec 22

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.78

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for MGRO.V

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.76

52W High$2.09

52W Low$0.50

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$398,018	$4.71M	$6,479	$12,869	N/A
Gross Profit	$300,755	$4.33M	$6,479	$12,869	N/A
Gross Margin	75.6%	91.8%	100.0%	100.0%	N/A
Operating Income	$-5,114,172	$-804,988	$-5,555,775	$-3,011,110	$-3,369,248
Net Income	$-4,888,722	$-676,940	$-5,565,841	$-3,063,875	$-3,355,798
Net Margin	-1228.3%	-14.4%	-85905.9%	-23808.2%	N/A
EPS	$-0.09	$-0.01	$-0.11	$-0.07	$-0.09

Company Overview

MustGrow Biologics Corp., an agricultural biotech company, focuses om development and commercialization of natural biopesticide, biofumigants, and bioherbicides derived from mustard seed. It provides preplant soil biofumigation, a technology to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and other crops. The company is also developing bioherbicide to treat unwanted plant growth for use in organic agriculture, home, and garden markets, as well as agriculture markets; and postharvest food preservation, an application in sprout, disease, and pathogen treatment for storage and food preservation markets. In addition, it focuses on providing CannaPM, an active ingredient to treat fungal soil diseases, as well as foliar diseases. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.

Visit Website

Earnings History & Surprises

MGRO.V

Beat Rate

17%

Last 12 quarters

Avg Surprise

-21.1%

EPS vs Estimate

Beats / Misses

2/5

5 met exactly

Latest EPS

$-0.04

Q4 2025

EPS Surprise History

Q4 23

No data

Q2 24

0.0%

$-0.02vs$-0.02

Q3 24

0.0%

$-0.02vs$-0.02

Q4 24

+25.0%

$-0.03vs$-0.04

Q4 24

No data

Q2 25

0.0%

$-0.02vs$-0.02

Q3 25

+47.8%

$-0.02vs$-0.04

Q4 25

-122.0%

$-0.04vs$-0.02

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	Apr 21, 2026	—	—	—	—
Q4 2025	Nov 25, 2025	$-0.02	$-0.04	-122.0%	✗ MISS
Q3 2025	Aug 27, 2025	$-0.04	$-0.02	+47.8%	✓ BEAT
Q2 2025	May 27, 2025	$-0.02	$-0.02	0.0%	= MET
Q4 2024	Dec 31, 2024	—	$-0.02	—	—
Q4 2024	Nov 27, 2024	$-0.04	$-0.03	+25.0%	✓ BEAT
Q3 2024	Aug 28, 2024	$-0.02	$-0.02	0.0%	= MET
Q2 2024	May 29, 2024	$-0.02	$-0.02	0.0%	= MET
Q4 2023	Dec 31, 2023	—	$0.07	—	—
Q4 2023	Nov 29, 2023	$-0.02	$-0.04	-100.0%	✗ MISS
Q3 2023	Aug 29, 2023	$-0.02	$-0.02	-20.8%	✗ MISS
Q2 2023	May 26, 2023	$-0.02	$-0.02	0.0%	= MET
Q4 2022	Dec 31, 2022	—	$-0.02	—	—
Q4 2022	Nov 30, 2022	$-0.03	$-0.04	-33.3%	✗ MISS
Q3 2022	Aug 26, 2022	$-0.02	$-0.03	-50.0%	✗ MISS
Q2 2022	May 26, 2022	$-0.01	$-0.01	0.0%	= MET
Q4 2021	Dec 31, 2021	—	$-0.02	—	—
Q4 2021	Nov 24, 2021	—	$-0.02	—	—
Q3 2021	Aug 25, 2021	—	$-0.02	—	—
Q2 2021	May 27, 2021	—	$-0.01	—	—

Frequently Asked Questions about MGRO.V

What is MGRO.V's current stock price?

MustGrow Biologics Corp. (MGRO.V) is currently trading at $0.71 per share. The stock has moved +4.41% today.

What is the analyst price target for MGRO.V?

No analyst price targets are currently available for this stock.

What sector is MustGrow Biologics Corp. in?

MustGrow Biologics Corp. operates in the Basic Materials sector, specifically within the Agricultural Inputs industry. The company is traded on the TSXV exchange.

What is MGRO.V's market cap?

MustGrow Biologics Corp. has a market capitalization of $0.04 billion, making it a small-cap company.

Does MGRO.V pay dividends?

No, MustGrow Biologics Corp. does not currently pay a dividend to shareholders.